Emmanuelle Coutanceau is a Partner at Novo Seeds, the early-stage life-science venture arm of Novo Holdings. See sector focus and contact routes.
Emmanuelle Coutanceau is a Partner at Novo Seeds, the early-stage life-science venture arm of Novo Holdings, where she focuses on seed and pre-seed investments in Scandinavian biotech projects with commercial potential. She has backed notable companies including IO Biotech (invested at seed stage in 2014, now an oncology-focused firm) and Coave Therapeutics (joined its board during its €32M Series A for genetic medicines). Her distinctive thesis centers on building successful companies from innovative science, providing capital, knowledge, and network to transform applied groundbreaking research into viable life-science enterprises.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Copenhagen.
Investors like Emmanuelle Coutanceau · Full investor directory · Investor access · Company funding database